Skip to main content
opens in a new window
TECHNOLOGY
TECHNOLOGY
LENSAR Laser System
ALLY Adaptive Cataract Treatment System
ABOUT US
INVESTORS
CONTACT US
SUPPORT
SUPPORT
Marketing Portal
Clinical Training
Certificates and Supplies
Electronic User Manuals
HOME
TECHNOLOGY
ABOUT US
INVESTORS
CONTACT US
SUPPORT
News
Investors Menu
Overview
News
Events & Presentations
Stock Information
Stock Quote
Stock Chart
Analyst Coverage
Financials
Annual Reports
SEC Filings
Governance
Governance Documents
Executive Management
Board of Directors
Committee Composition
Whistleblower
Resources
Investor Email Alerts
Investor Contacts
Normal
Press release year list
2022
2021
2020
2019
2018
2017
September 08, 2022
LENSAR Announces Application for Certification of the ALLY™ Adaptive Cataract Treatment System in the EU
August 16, 2022
First Patients Treated with LENSAR’s® ALLY™ Adaptive Cataract Treatment System
August 08, 2022
LENSAR Reports Second Quarter 2022 Financial Results and Provides Business Update
August 01, 2022
LENSAR to Report Second Quarter 2022 Financial Results on Monday, August 8, 2022
June 13, 2022
LENSAR® Receives U.S. FDA Clearance of ALLY™ Adaptive Cataract Treatment System
May 09, 2022
LENSAR Reports First Quarter 2022 Financial Results and Provides Business Update
May 02, 2022
LENSAR to Report First Quarter 2022 Financial Results on Monday, May 9, 2022
March 03, 2022
LENSAR Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
March 01, 2022
LENSAR Announces U.S. Food and Drug Administration Acceptance of 510(k) Submission for ALLY
February 28, 2022
LENSAR to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, March 3, 2022
February 10, 2022
LENSAR to Participate in Two Upcoming Investor Conferences
January 04, 2022
LENSAR to Present at the H.C. Wainwright Virtual BioConnect Conference